Accolade Inc (ACCD) Stock Analysis

$7.020

-0.010 (-0.14%)At close

Loading chart…

High: 7.030
Open: 7.030
VWAP: 7.02
Vol: 4.59M
Mkt Cap: 511.25M
Low: 7.010
Amount: 32.19M
EV/EBITDA, TTM: 16.63

Accolade, Inc. provides personalized, technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. Its customers are primarily employers that deploy Accolade solutions in order to provide employees and their families with a single place to turn for their health, healthcare, and benefits needs. It also offers medical opinion services to commercial customers and virtual primary care and mental health support. Its platform, True Health Engine, combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. Its offerings include Accolade Expert MD, Accolade Care, Plus and Connect and Accolade One.

www.accolade.com

Valuation Metrics

The current forward P/E ratio for Accolade Inc (ACCD) is -50.82, compared to its 5-year average forward P/E of -19.02.

Forward P/E

Strongly Undervalued

5Y Average P/E

-19.02

Current P/E

-50.82

Overvalued

-8.52

Undervalued

-29.51

Forward EV/EBITDA

Fair

5Y Average EV/EBITDA

-24.70

Current EV/EBITDA

16.63

Overvalued

119.18

Undervalued

-168.57

Forward P/S

Fair

5Y Average P/S

2.20

Current P/S

1.10

Overvalued

3.92

Undervalued

0.47

Events Timeline

2025-04-22 (ET)

08:30:04

Thirteen option delistings on April 22nd

2025-03-27 (ET)

16:21:57

Accolade announces stockholder approval for Transcarent merger

2025-02-24 (ET)

17:22:32

Accolade and Transcarent announce HSR waiting period expiration for merger

2025-01-13 (ET)

06:08:49

Accolade downgraded to Hold from Buy at Truist

2025-01-08 (ET)

12:15:09

Accolade downgraded to Hold from Buy at Needham

Show More Events

News

ACCD FAQ — answered by Alphio AI

Accolade, Inc. provides personalized, technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. Its customers are primarily employers that deploy Accolade solutions in order to provide employees and their families with a single place to turn for their health, healthcare, and benefits needs. It also offers medical opinion services to commercial customers and virtual primary care and mental health support. Its platform, True Health Engine, combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. Its offerings include Accolade Expert MD, Accolade Care, Plus and Connect and Accolade One. It operates in the Healthcare sector (SERVICES-BUSINESS SERVICES, NEC industry).

本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。